Patient Assistance Resources

Technology and Education

Payment Assistance Programs for Prespeciption Drugs

Patients with chronic retinal diseases like age-related macular degeneration (AMD) often can’t afford the out-of-pocket co-pay costs for the prescription drugs needed to treat their conditions. 

Privately insured patients, including those who purchase insurance through Obamacare’s insurance exchanges, can seek assistance directly from pharmaceutical-sponsored and independent programs.

Below is a listing of some of these programs with links for more information. Availability and eligibility for these programs could change at any time, so contact program representatives for current information.

Pharmaceutical-sponsored programs

Allergan, Inc.:

Allergan offers patient assistance for dexamethasone (Ozurdex®) for treatment of retinal vein occlusion (RVO), diabetic macular edema and uveitis. (866) 698-7339, option 4

Bausch + Lomb:

Bausch + Lomb offers patients assistance for pegaptanib sodium (Macugen®) and verteporfin (Visudyne®). 


Lucentis Access Solutions offers several programs to assist patients in gaining access to Lucentis for treatment of macular diseases, RVO and diabetic retinopathy, including:

Regeneron Pharmaceuticals:


Independent programs

Several independent patient assistance programs (PAPs) offer benefits for patients with Medicare, Medicaid, and private insurance:

  • The Patient Access Network (PAN) Foundation ( offers assistance with copayments related to treatment for macular diseases, retinal vein occlusion (RVO) and uveitis. (800) 316-7263
  • The National Organization for Rare Disorders (NORD) ( has offered PAPS since 1987 to help patients obtain medication, financial assistance with insurance premiums and co-pays, diagnostic testing, and travel assistance for clinical trials, consultations and disease specialists.  NORD offers disease-specific assistance programs for patients with RVO and uveitis. (800) 999-6673, ext. 219
  • The Chronic Disease Fund (CDF) ( provides assistance with co-pays/co-insurance for treatment associated with age-related macular degeneration (AMD) and RVO.  (877) 968-7233